{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:01:17Z","timestamp":1791860477798,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009756","name":"Sarcoma UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011719","name":"Bone Cancer Research Trust","doi-asserted-by":"publisher","award":["SUK106.2018"],"award-info":[{"award-number":["SUK106.2018"]}],"id":[{"id":"10.13039\/100011719","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejca.2026.116981","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T06:49:28Z","timestamp":1786171768000},"page":"116981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service"],"prefix":"10.1016","volume":"246","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6571-0298","authenticated-orcid":false,"given":"Reuben A.","family":"Hastings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7706-8586","authenticated-orcid":false,"given":"Victoria","family":"Vinader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Gains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"McPhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3879-5377","authenticated-orcid":false,"given":"Lizz","family":"Paley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3043-4507","authenticated-orcid":false,"given":"Craig","family":"Gerrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5138-0707","authenticated-orcid":false,"given":"Martin G.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8328-0260","authenticated-orcid":false,"given":"Sandra J.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.116981_bib1","unstructured":"National Cancer Intelligence Network. Bone Sarcomas: incidence and survival rates in England. 2010."},{"key":"10.1016\/j.ejca.2026.116981_bib2","unstructured":"WHO. International Classification of Diseases 10th revision. https:\/\/icd.who.int\/browse10\/2019\/en; 2019."},{"key":"10.1016\/j.ejca.2026.116981_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyz076","article-title":"Data resource profile: national cancer registration dataset in England","volume":"49","author":"Henson","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ejca.2026.116981_bib4","unstructured":"WHO. Soft Tissue and Bone Tumours: WHO Classification of Tumours. vol. 3. 5th ed. 2013."},{"key":"10.1016\/j.ejca.2026.116981_bib5","article-title":"International rules for multiple primary cancers (ICD-0 third edition)","volume":"14","author":"Report","year":"2005","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.ejca.2026.116981_bib6","doi-asserted-by":"crossref","first-page":"E508","DOI":"10.1002\/ijc.26426","article-title":"Incidence and survival of malignant bone sarcomas in England 1979\u20132007","volume":"131","author":"Whelan","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2026.116981_bib7","unstructured":"R. Core Team. R: A Language and Environment for Statistical Computing 2024."},{"key":"10.1016\/j.ejca.2026.116981_bib8","unstructured":"Eurostat. Revision of the European Standard Population - Report of Eurostat\u2019s task force - 2013 edition. 2013. https:\/\/doi.org\/10.2785\/11470."},{"key":"10.1016\/j.ejca.2026.116981_bib9","doi-asserted-by":"crossref","unstructured":"Ricardo T. (2026). joinpointR: Tidy Tools for Joinpoint Regression Models. R package version 1.0.0, https:\/\/CRAN.R-project.org\/package=joinpointR.","DOI":"10.32614\/CRAN.package.joinpointR"},{"key":"10.1016\/j.ejca.2026.116981_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v087.i08","article-title":"Nonparametric relative survival analysis with the r package relsurv","volume":"87","author":"Perme","year":"2018","journal-title":"J Stat Softw"},{"issue":"3","key":"10.1016\/j.ejca.2026.116981_bib11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/biom.12477","article-title":"A log-rank-type test to compare net survival distributions","volume":"72","author":"Graff\u00e9o","year":"2016","journal-title":"Biometrics"},{"key":"10.1016\/j.ejca.2026.116981_bib12","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.ejca.2004.07.002","article-title":"Standard cancer patient population for age standardising survival ratios","volume":"40","author":"Corazziari","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116981_bib13","unstructured":"NHS England. NHS Imaging and Radiodiagnostic activity in England: 2012\/13 Release. August 2013. https:\/\/www.england.nhs.uk\/statistics\/wp-content\/uploads\/sites\/2\/2013\/04\/KH12-release-2012-13.pdf."},{"key":"10.1016\/j.ejca.2026.116981_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jcot.2021.02.017","article-title":"The changing face of central chondrosarcoma of bone. One UK-based orthopaedic oncology unit\u2019s experience of 33 years referrals","volume":"17","author":"Davies","year":"2021","journal-title":"J Clin Orthop Trauma"},{"key":"10.1016\/j.ejca.2026.116981_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12885-020-6683-0","article-title":"Incidence and time trends of sarcoma (2000\u20132013): results from the French network of cancer registries (FRANCIM)","volume":"20","author":"Amadeo","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2026.116981_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2019.101596","article-title":"Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015","volume":"63","author":"Koll\u00e1r","year":"2019","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ejca.2026.116981_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2023.102449","article-title":"Steady survival improvements in soft tissue and bone sarcoma in the Nordic countries through 50 years","volume":"92","author":"Tichanek","year":"2024","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ejca.2026.116981_bib18","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ejca.2012.09.011","article-title":"Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project","volume":"49","author":"Stiller","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116981_bib19","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.suronc.2018.05.009","article-title":"Incidence, outcomes and prognostic factors during 25 years of treatment of chondrosarcomas","volume":"27","author":"van Praag (Veroniek)","year":"2018","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ejca.2026.116981_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/0284186X.2018.1554260","article-title":"Chondrosarcoma in Norway 1990\u20132013; an epidemiological and prognostic observational study of a complete national cohort","volume":"58","author":"Thorkildsen","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2026.116981_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/0284186X.2023.2177975","article-title":"The national incidence of chondrosarcoma of bone; a review","volume":"62","author":"Thorkildsen","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2026.116981_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-020-03511-x","article-title":"Descriptive epidemiology of chordomas in the United States","volume":"148","author":"Das","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ejca.2026.116981_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2024.102527","article-title":"Incidence and centralization of chordoma in the Netherlands: a nationwide study between 1991 and 2020","volume":"89","author":"Lipplaa","year":"2024","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ejca.2026.116981_bib24","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/ijc.27402","article-title":"The contrasting age-incidence patterns of bone tumours in teenagers and young adults: implications for aetiology","volume":"131","author":"Arora","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2026.116981_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canep.2019.03.002","article-title":"Bone sarcoma incidence in the Netherlands","volume":"60","author":"Goedhart","year":"2019","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ejca.2026.116981_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2024.100613","article-title":"From bimodal to unimodal: the transformed incidence of osteosarcoma in the United States","volume":"47","author":"Kar","year":"2024","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.ejca.2026.116981_bib27","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1093\/rheumatology\/keab232","article-title":"Incidence of Paget\u2019s disease of bone in the UK: evidence of a continuing decline","volume":"60","author":"Cook","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejca.2026.116981_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.canep.2018.08.010","article-title":"Survival of adults with cancers of bone or soft tissue in Europe\u2014Report from the EUROCARE-5 study","volume":"56","author":"Stiller","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ejca.2026.116981_bib29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ijc.34694","article-title":"Twenty-year outcome of prevalence, incidence, mortality and survival rate in patients with malignant bone tumors","volume":"154","author":"Xu","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2026.116981_bib30","unstructured":"National Institute for Health and Care Excellence. Improving outcomes for people with sarcoma. United Kingdom: https:\/\/www.nice.org.uk\/guidance\/csg9; 2006."},{"key":"10.1016\/j.ejca.2026.116981_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13569-016-0047-1","article-title":"UK guidelines for the management of bone sarcomas","volume":"6","author":"Gerrand","year":"2016","journal-title":"Clin Sarcoma Res"},{"key":"10.1016\/j.ejca.2026.116981_bib32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1302\/0301-620X.103B3.BJJ-2020-0743.R1","article-title":"Impact of NICE guidelines on the survival of patients with soft-tissue sarcomas","volume":"103-B","author":"Fujiwara","year":"2021","journal-title":"Bone Jt J"},{"key":"10.1016\/j.ejca.2026.116981_bib33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.clon.2023.02.009","article-title":"Outcomes of patients treated in the UK proton overseas programme: non-central nervous system group","volume":"35","author":"Hwang","year":"2023","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116981_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114209","article-title":"The survival disparity between children and adolescents and young adults (AYAs) with Ewing sarcoma in the Netherlands did not change since the 1990s despite improved survival: a population-based study","volume":"208","author":"Schulpen","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116981_bib35","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/cncr.31958","article-title":"The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: an analysis of the National Cancer Data Base","volume":"125","author":"Palm","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2026.116981_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejca.2018.11.027","article-title":"Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort","volume":"109","author":"Smeland","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2026.116981_bib37","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/cancers13030388","article-title":"Surgical advances in osteosarcoma","volume":"13","author":"Brookes","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2026.116981_bib38","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/15563316211028137","article-title":"Computer-assisted surgical navigation for primary and metastatic bone malignancy of the pelvis: current evidence and future directions","volume":"17","author":"Christ","year":"2021","journal-title":"HSS J\u00ae"},{"key":"10.1016\/j.ejca.2026.116981_bib39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/0284186X.2019.1695064","article-title":"Female gender in the hormonally active age group plays a major role in high-grade chondrosarcoma survival","volume":"59","author":"Laitinen","year":"2020","journal-title":"Acta Oncol"}],"updated-by":[{"DOI":"10.1016\/j.ejca.2026.117062","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:00:00Z","timestamp":1794873600000}}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926007628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926007628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:09:52Z","timestamp":1789056592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926007628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"alternative-id":["S0959804926007628"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116981","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116981"}}